On October 30, 2024, John Replogle, a Director at Crocs Inc (CROX, Financial), purchased 2,240 shares of the company, as reported in a recent SEC Filing. This transaction increased the insider's holdings to 9,304 shares.
Crocs Inc, known for its innovative casual footwear for men, women, and children, has seen varied activities from its insiders over the past year. The insider transaction history shows a total of 3 insider buys and 15 insider sells within the last twelve months.
Shares of Crocs Inc were trading at $112.6 on the day of the transaction. The company currently holds a market cap of approximately $6.35 billion. The price-earnings ratio of Crocs Inc stands at 8.20, which is lower than both the industry median of 19.07 and the company's historical median.
The GF Value of Crocs Inc is estimated at $131.93, suggesting that the stock is Modestly Undervalued with a price-to-GF-Value ratio of 0.85.
The GF Value is calculated considering historical multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
Overall, the insider's recent purchase adds to the total of 6,208 shares bought over the past year, indicating a positive sentiment towards the stock within the company's leadership.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.